Americans who suffer adverse reactions to coronavirus vaccines that the U.S. is racing to develop will have a hard time getting compensated for injuries from the drugs. That’s because pandemic-related claims for vaccines will be routed to a rarely used federal program set up to encourage drugmakers to help combat public health emergencies. It spares… Continue reading The Rush for a Vaccine Leaves Little Recourse for Anyone It Harms
Looking For Market Distribution? Download the Media Kit
